SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS) -- Ignore unavailable to you. Want to Upgrade?


To: topvest who wrote (671)7/17/1998 11:53:00 AM
From: William J. Leiby  Read Replies (1) | Respond to of 849
 
Top: About a month prior to the NuMa fiasco with the FDA I wrote a letter to the CEO asking basically the same questions. Unfortuantely, I included my fax number on the letter. He faxed back to call him. I decided not to call because I had two previous phone conversations which really went nowhere. He seems a very decent and nice man, but not direct. I can't help but think things aren't quite computing.

Until I see Mr Corbett buy back his 30000 shares and some others buying, I will remain quite skeptical.

Also, I wonder about the CFO departure. Would you leave (with your options and with supposed wonderful announcements just around the corner) just because you are tired of a one-hour commute?

My guess is you are very knowledgeable and can talk science. How about faxing your questions to the CEO and ask for a dialogue? I, for one, would certainly appreciate it.

Thanks, Bill



To: topvest who wrote (671)7/17/1998 12:24:00 PM
From: Damon Pham  Read Replies (1) | Respond to of 849
 
Here's the link to the article that topvest is referring to:

ncbi.nlm.nih.gov

There's also another article in progress on NMP22 that I thougt was interesting.

ncbi.nlm.nih.gov